King Mongkut’s University of Technology Thonburi (KMUTT), in collaboration with the Government Pharmaceutical Organization (GPO) and the National Vaccine Institute (NVI), held a collaborative meeting to discuss the development of an H7N9 influenza vaccine.
Date: January 9, 2024
Venue: Prapha Prachaksuphaniti Meeting Room (AD907), 9th Floor, Office of the President Building, KMUTT Bangmod Campus
On Tuesday, January 9, 2024 ASSOC. PROF. DR.SUVIT SAETIA Board Member King Mongkut’s University of Technology Thonburi (KMUTT), ASSOC. PROF. DR. SOLOT SUWANAYUEN Vice President Bangkhuntien, ASST. PROF. DR. MARONG PHADOONGSIDHI Vice President for Finance, Property and Information, Asst.Prof.Dr. Sansanalak Rachdawong, Director of the National Biopharmaceutical Production Pilot Plant (NBF), KMUTT, and advisor to the National Biopharmaceutical Production Pilot Plant, KMUTT, met to discuss. 2nd Vaccine Production Development Cooperation with the National Vaccine Institute and the Government Pharmaceutical Organization, led by the Director of the National Vaccine Institute, Deputy Director of the National Vaccine Institute, Deputy Director of the Government Pharmaceutical Organization and administrators of the Government Pharmaceutical Organization According to the project plan to develop the production of inactivated H7N9 influenza vaccine using cell culture technology. To expand to a semi-industrial level It will use the production technology of SK Bioscience Company Limited, South Korea. and the National Biopharmaceutical Production Model Factory, KMUTT, is a semi-industrial production facility at meeting room AD-907, 9th floor, Office of the President, KMUTT.